Guardant Health (GH) expects full year 2026 non-GAAP gross margin to be in the range of 64% to 65%. Guardant Health expects total non-GAAP operating expenses to be in the range of $1.03 to $1.05 billion, representing a 14% to 16% increase compared to 2025. Guardant Health expects free cash flow burn to be in the range of $185 to $195 million in 2025, an improvement compared to $233 million for the full year 2025.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GH:
- Guardant Health initiated with an Outperform at Baird
- GH Earnings Report this Week: Is It a Buy, Ahead of Earnings?
- The Week That Was, The Week Ahead: Macro and Markets, Feb. 15
- Cathie Wood Pours $10.4M into Alphabet (GOOG) and Sells $19.6M Coinbase Stock, 2/9/26
- Guardant reports publication of circulating tumor DNA for MRD detection study